Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.

MLA

Om, Kier, et al. “Adjuvanted HIV-1 Vaccine Promotes Antibody-Dependent Phagocytic Responses and Protects against Heterologous SHIV Challenge.” PLoS Pathogens, vol. 16, no. 9, Sept. 2020, p. e1008764. EBSCOhost, https://doi.org/10.1371/journal.ppat.1008764.

APA

Om, K., Paquin-Proulx, D., Montero, M., Peachman, K., Shen, X., Wieczorek, L., Beck, Z., Weiner, J. A., Kim, D., Li, Y., Mdluli, T., Shubin, Z., Bryant, C., Sharma, V., Tokarev, A., Dawson, P., White, Y., Appelbe, O., Klatt, N. R., … Bolton, D. L. (2020). Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. PLoS Pathogens, 16(9), e1008764. https://doi.org/10.1371/journal.ppat.1008764

Chicago

Om, Kier, Dominic Paquin-Proulx, Maria Montero, Kristina Peachman, Xiaoying Shen, Lindsay Wieczorek, Zoltan Beck, et al. 2020. “Adjuvanted HIV-1 Vaccine Promotes Antibody-Dependent Phagocytic Responses and Protects against Heterologous SHIV Challenge.” PLoS Pathogens 16 (9): e1008764. doi:10.1371/journal.ppat.1008764.